Clinical Trials Directory

Trials / Terminated

TerminatedNCT00795587

Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring

Compared Effects of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Will an increase of the dose of mannitol improve the effects on neuromonitoring in patients suffering intracranial hypertension following traumatic brain injury?

Detailed description

traumatic brain injury intracranial hypertension 0,4 g/ kg vs 0,8 g/ kg (randomized) on 20 minutes monitoring: ICP, transcranial doppler, brain pO2, MAP, HR, diuresis, biology duration: 2 hours

Conditions

Interventions

TypeNameDescription
DRUGvariation of mannitol dosein case of intracranial hypertension up to 20 mmHg lasting more than 10 minutes and without nociceptive stimulation or systemic instability: injection of either 0.4 g/ kg or 0.8 g/ kg of mannitol 20% (randomized) on 20 minutes, with monitoring of neurologic, systemic and biologic datas during 120 minutes

Timeline

Start date
2008-10-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2008-11-21
Last updated
2012-11-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00795587. Inclusion in this directory is not an endorsement.